A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules

Trial Details

NCT ID

NCT04905056

Phase

PHASE2

Sponsor

Shanghai Zhongshan Hospital

Status

RECRUITING

Cancer Type

Lung Cancer

Interventions

• Ablation therapy

Locations (sample)

• Shanghai, Shanghai Municipality, China|31.22222,121.45806

Key Eligibility Criteria

• Aged between 18 and 85 years;
• GGO is diagnosed by lung CT and failure to subside after 3 months (the patient having been re-examined by thin-section CT);
• The maximum diameter of the GGO is bigger than 8mm and smaller than 3cm;
• For single GGO: obvious progress was observed in pure GGO or the solid component of mixed ground glass nodules was more than or equal to 2 mm

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.